** Shares of medical equipment maker West Pharmaceutical Services rise 9.97% to $315.01 premarket
** Co raises annual adj. profit forecast to be between $6.55 and $6.75 per share vs prior range of $6.35 to $6.65 per share
** Expects full-year revenue forecast to be between $2.88 billion and $2.91 billion, up from the prior range of $2.87 billion to $2.90 billion
** Analysts, on average, were expecting annual profit of $6.51 per share and total revenue of $2.87 billion - LSEG
** Posts Q3 adj. profit of $1.85/shr vs analysts' estimates of $1.50/shr
** As of last close, stock down 18.6% YTD
(Reporting by Sruthi Narasimha Chari and Sriparna Roy in Bengaluru)
((Sruthinarasimha.chari@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。